The Christie Charity
1. NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma.
S Mukherjee, CN Hurt, S Gwynne, D Sebag-Montefiore, G Radhakrishna, S Gollins, M Hawkins, HI Grabsch, G Jones, S Falk, R Sharma, A Bateman, R Roy, R Ray, J Canham, G Griffiths, T Maughan, T Crosby.
European Journal of Cancer 2017. 74, 36-46.
2. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.
van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M, Jiménez D, Portillo AK, O'Connell C, Liebman HA, Shteinberg M, Adir Y, Tiseo M, Bersanelli M, Abdel-Razeq HN, Mansour AH, Donnelly OG, Radhakrishna G, Ramasamy S, Bozas G, Maraveyas A, Shinagare AB, Hatabu H, Nishino M, Huisman MV, Klok FA.
J Thromb Haemost. 2016 Jan;14(1):105-13. doi: 10.1111/jth.13172. Epub 2016 Jan 11.
PMID: 26469193
3. NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
Mukherjee S, Hurt CN, Gwynne S, Bateman A, Gollins S, Radhakrishna G, Hawkins M, Canham J, Lewis W, Grabsch HI, Sharma RA, Wade W, Maggs R, Tranter B, Roberts A, Sebag-Montefiore D, Maughan T, Griffiths G, Crosby T.
BMC Cancer. 2015 Feb 12;15:48. doi: 10.1186/s12885-015-1062-y.
PMID: 25880814 Free PMC Article
4. Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.
Rembielak AI, Jain P, Jackson AS, Green MM, Santorelli GR, Whitfield GA, Crellin A, Garcia-Alonso A, Radhakrishna G, Cullen J, Taylor MB, Swindell R, West CM, Valle J, Saleem A, Price PM.
Transl Oncol. 2014 Feb 1;7(1):55-64. eCollection 2014 Feb.
PMID: 24772208 Free PMC Article
5. Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
Gwynne S, Falk S, Gollins S, Wills L, Bateman A, Cummins S, Grabsch H, Hawkins MA, Maggs R, Mukherjee S, Radhakrishna G, Roy R, Sharma RA, Spezi E, Crosby T.
Clin Oncol (R Coll Radiol). 2013 Jun;25(6):368-77. doi: 10.1016/j.clon.2013.01.006. Epub 2013 Mar 11.
PMID: 23489868
6. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
Mukherjee S, Hurt CN, Bridgewater J, Falk S, Cummins S, Wasan H, Crosby T, Jephcott C, Roy R, Radhakrishna G, McDonald A, Ray R, Joseph G, Staffurth J, Abrams RA, Griffiths G, Maughan T.
Lancet Oncol. 2013 Apr;14(4):317-26. doi: 10.1016/S1470-2045(13)70021-4. Epub 2013 Mar 6.
PMID: 23474363 Free PMC Article
7. Commentary on: Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Chowdhury FU, Radhakrishna G, Godfrey EM.
Clin Radiol. 2013 Apr;68(4):338-9. doi: 10.1016/j.crad.2012.10.002. Epub 2012 Nov 17. No abstract available.
PMID: 23164464
8. Cancer-related venous thromboembolic disease: current management and areas of uncertainty.
Radhakrishna G, Berridge D.
Phlebology. 2012;27 Suppl 2:53-60. doi: 10.1258/phleb.2012.012S34. Review.
PMID: 22457305